← Leaderboards
David McDermott
Beth Israel Deaconess Medical Center
$9,360,637
Attributed
$10,606,823
Total exposure
12
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$40,924,462 · 13
By mechanism
P50$35,615,742 · 9
U01$3,144,828 · 1
R01$1,634,373 · 1
P30$529,519 · 2
Top collaborators
- William G Kaelin11 shared
- Marston Linehan4 shared
- Ramaprasad Srinivasan4 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Pankaj K Seth$2,314,684
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelRenal CarcinomaProgramsDana-Farber Cancer InstituteFundingClinical TrialsPathway InteractionsBaseCancer CenterMalignant NeoplasmsInstitutionCollaborationsPre-Clinical ModelGrantFutureEvaluationMolecularToxic EffectSuccessPredictive MarkerMemberClear Cell Renal Cell CarcinomaKidney NeoplasmsTumor
Grant awards (62)
DF/HCC Kidney Cancer SPORE (supplement)$1,230,080
P50 · FY2025 · CA · contact PI
Developing a Translation Pipeline for VHL Mutant Malignancies$606,369
U01 · FY2025 · CA · contact PI
Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma$382,146
R01 · FY2025 · CA · contact PI
DF/HCC Kidney Cancer SPORE Administrative Core$141,448
P50 · FY2025 · CA · contact PI
Project 3: HHLA2 as a THerapeutic Target in RCC$37,502
P50 · FY2025 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,219,550
P50 · FY2024 · CA · contact PI
Developing a Translation Pipeline for VHL Mutant Malignancies$669,180
U01 · FY2024 · CA · contact PI
Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma$374,169
R01 · FY2024 · CA · contact PI
Project 3: HHLA2 as a THerapeutic Target in RCC$241,930
P50 · FY2024 · CA · contact PI
DF/HCC Kidney Cancer SPORE Administrative Core$201,069
P50 · FY2024 · CA · contact PI
Development Research Project (DRP)$143,548
P50 · FY2024 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,188,219
P50 · FY2023 · CA · contact PI
Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma$423,811
R01 · FY2023 · CA · contact PI
Project 3: HHLA2 as a THerapeutic Target in RCC$241,778
P50 · FY2023 · CA · contact PI
DF/HCC Kidney Cancer SPORE Administrative Core$200,918
P50 · FY2023 · CA · contact PI
Development Research Project (DRP)$143,395
P50 · FY2023 · CA · contact PI
Program 52: Kidney Cancer$42,383
P30 · FY2023 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,148,449
P50 · FY2022 · CA · contact PI
Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma$454,247
R01 · FY2022 · CA · contact PI
Developing a Translation Pipeline for VHL Mutant Malignancies$400,168
U01 · FY2022 · CA · contact PI
DF/HCC Kidney Cancer SPORE Administrative Core$279,413
P50 · FY2022 · CA · contact PI
Project 3: HHLA2 as a THerapeutic Target in RCC$246,071
P50 · FY2022 · CA · contact PI
Development Research Project (DRP)$187,257
P50 · FY2022 · CA · contact PI
Program 52: Kidney Cancer$42,383
P30 · FY2022 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,272,484
P50 · FY2021 · CA · contact PI
Developing a Translation Pipeline for VHL Mutant Malignancies$408,334
U01 · FY2021 · CA · contact PI
DF/HCC Kidney Cancer SPORE Administrative Core$284,061
P50 · FY2021 · CA · contact PI
Development Research Project (DRP)$284,060
P50 · FY2021 · CA · contact PI
Project 3: HHLA2 as a THerapeutic Target in RCC$284,060
P50 · FY2021 · CA · contact PI
Program 52: Kidney Cancer$76,748
P30 · FY2021 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,543,224
P50 · FY2020 · CA · contact PI
Developing a Translation Pipeline for VHL Mutant Malignancies$410,974
U01 · FY2020 · CA · contact PI
Development Research Project (DRP)$335,402
P50 · FY2020 · CA · contact PI
DF/HCC Kidney Cancer SPORE Administrative Core$298,032
P50 · FY2020 · CA · contact PI
Project 3: HHLA2 as a THerapeutic Target in RCC$270,115
P50 · FY2020 · CA · contact PI
Program 52: Kidney Cancer$80,434
P30 · FY2020 · CA · contact PI
Program 52: Kidney Cancer$2,948
P30 · FY2020 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,139,000
P50 · FY2019 · CA · contact PI
Developing a Translation Pipeline for VHL Mutant Malignancies$649,803
U01 · FY2019 · CA · contact PI
Administrative Evaluation and Planning Core$183,594
P50 · FY2019 · CA · contact PI
Trageting mTOR Dependent Mechanism in Clear Cell Renal Carcinoma$178,707
P50 · FY2019 · CA · contact PI
DF/HCC Kidney Cancer SPORE Development Research Projects$177,995
P50 · FY2019 · CA · contact PI
Program 52: Kidney Cancer$92,025
P30 · FY2019 · CA · contact PI
Program 52: Kidney Cancer$6,167
P30 · FY2019 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,300,000
P50 · FY2018 · CA · contact PI
Administrative Evaluation and Planning Core$242,111
P50 · FY2018 · CA · contact PI
DF/HCC Kidney Cancer SPORE Development Research Projects$227,406
P50 · FY2018 · CA · contact PI
Program 52: Kidney Cancer$93,630
P30 · FY2018 · CA · contact PI
Program 52: Kidney Cancer$11,429
P30 · FY2018 · CA · contact PI
Program 52: Kidney Cancer$5,848
P30 · FY2018 · CA · contact PI
Program 52: Kidney Cancer$5,123
P30 · FY2018 · CA · contact PI
Program 52: Kidney Cancer$3,833
P30 · FY2018 · CA · contact PI
Program 52: Kidney Cancer$1,601
P30 · FY2018 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,300,000
P50 · FY2017 · CA · contact PI
Administrative Evaluation and Planning Core$241,424
P50 · FY2017 · CA · contact PI
DF/HCC Kidney Cancer SPORE Development Research Projects$226,807
P50 · FY2017 · CA · contact PI
Program 52: Kidney Cancer$64,967
P30 · FY2017 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,156,131
P50 · FY2016 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,185,000
P50 · FY2015 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,150,502
P50 · FY2013 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,300,000
P50 · FY2012 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,185,000
P50 · FY2011 · CA · contact PI